Fox-news/health/healthy-living/medications

• Oprah Winfrey reveals 'shame' of weight-loss drugs and what happened when she quit - Oprah Winfrey discusses GLP-1 weight-loss medications and obesity as a disease, challenging long-held misconceptions about willpower and food addiction.
• What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients - Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.
• Deadly 'superbug' is spreading across US as drug resistance grows, researchers warn - Researchers discover possible weakness in deadly hospital superbug C. auris that could lead to new treatments for the drug-resistant fungal infection.
• Cancer drug combo shows promise for patients resistant to standard treatments - Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, offering hope for difficult AML cases.
• Diabetes patients experience lower death rate with common medication - New research finds statins benefit adults with type 2 diabetes across all heart-risk levels, reducing deaths and serious cardiovascular events.
• Alzheimer’s disease could be reversed by restoring brain balance, study suggests - A new method of reversing Alzheimer's shows promise in an animal study, as researchers at University Hospitals restore brain energy molecule NAD+.
• Obesity expert reveals the best way to decide if GLP-1s are right for you - Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether GLP-1 weight-loss medications are right for you.
• New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests - Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while preserving muscle mass in diabetes patients.
• New baldness treatment shows dramatic hair-regrowth gains in major trial - New topical hair loss treatment shows a 539% improvement in trials, offering hope for male-pattern baldness sufferers after decades without innovation.
• GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict - The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030.